Anti-Amyloid Drug May Lower Early-Onset Alzheimer’s Risk by 50%
Researchers tested a novel drug on people with a genetically inherited form of Alzheimer’s in a recent trial. It is almost impossible for someone who has dementia to prevent developing it. Gantenerumab helps remove amyloid plaques, which are one of the neurological characteristics of Alzheimer’s. The drug lowered some participants’ likelihood of developing the condition … Continue reading "Anti-Amyloid Drug May Lower Early-Onset Alzheimer’s Risk by 50%"